Advisory Services Network, LLC Biovie Inc. Transaction History

Advisory Services Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.22 - $5.24 $4,959 - $21,300	4,065 New	4,065 $5,000
Q1 2023 May 17, 2023	SELL	$4.89 - $10.53 $4,748 - $10,224	-971 Reduced 73.28%	354 $2,000
Q4 2022 Feb 13, 2023	BUY	$3.86 - $42.0 $5,114 - $55,650	1,325 New	1,325 $10,000
Q3 2021 Nov 05, 2021	SELL	$6.69 - $16.93 $2,174 - $5,502	-325 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$10.57 - $21.61 $3,435 - $7,023	325 New	325 $6,000

4.73M

17.2K

27K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $83.6M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.